Abstract:Gangliosides play vital biological regulatory roles and are associated with neurological system diseases, malignancies, and immune deficiencies. They have received extensive attention in developing targeted drugs and diagnostic markers. However, it is difficult to obtain enough structurally defined gangliosides and analogs especially at an industrial-relevant scale, which prevent exploring structure-activity relationships and identifying drug ingredients. Here, we report a highly modular chemoenzymatic cascade assembly (MOCECA) strategy for customized and large-scale synthesis of ganglioside analogs with various glycan and ceramide epitopes. We typically accessed five gangliosides with therapeutic promising and systematically prepared ten GM1 analogs with diverse ceramides. Through further process amplification, we achieved industrial production of ganglioside GM1 in the form of modular assembly at hectogram scale. Using MOCECA-synthesized GM1 analogs, we found unique ceramide modifications on GM1 could enhance the ability to promote neurite outgrowth. By comparing the structures with synthetic analogs, we further resolved the problem of contradicting descriptions for GM1 components in different pharmaceutical documents by reinterpreting the exact two-component structures of commercialized GM1 drugs. Because of its applicability and stability, the MOCECA strategy can be extended to prepare other glycosphingolipid structures, which may pave the way for developing new glycolipid drugs.

Synthesis of Per-acetyl Ganglioside GM3 Trisaccharide 4-Methoxyphenoside

Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3.

Efficient Synthesis of a Sialic Acid α(2→3)Galactose Building Block and Its Application to the Synthesis of Ganglioside GM3

Synthesis of N-modified ganglioside GM3 derivatives

Synthesis of complex carbohydrates and glyconjugates: enzymatic synthesis of globotetraose using alpha-1,3-N-acetylgalactosaminyltransferase LgtD from Haemophilus infuenzae strain Rd.

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

Novel Eco-Friendly Solution for the Regioselective Acetylation of Per-O-tms Carbohydrates.

Synthesis of oligosaccharides using per-O-trimethylsilyl-glycosyl iodides as glycosyl donor.

Synthesis Of The Galactoglycerolipids - I. The Synthesis Of 1,2-Di-O-Acyl-3-O-(Alpha-D-Galactopyranosyl)-Sn-Glycerols

Synthesis of the galactoglycerolipids I. The synthesis of 1,2-di-O-acyl-3-O-(α-D-galactopyranosyl)-sn-glycerols

Stereoselective synthesis of the trisaccharide moiety of ganglioside HLG-2.

An Efficient Procedure for Preparing Main Acylated Pentasaccharides from Polygalae Radix Using Integrated Extraction–adsorption Method Followed by Semi-Preparative High Performance Liquid Chromatography

Determination of disialoganglioside GD3 and monosialoganglioside GM3 in infant formulas and whey protein concentrates by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.

First Synthesis of 3′-Deoxy Lewisx Pentasaccharide

Chemo-enzymatic Synthesis of Neu5Gc-containing Sialylated Lactulose

Total synthesis of 4d-deoxy Lewisx pentasaccharide

Synthesis and Configuration of the Nonadecenetriol Isolated from Seeds of Persea Americana

Synthesis of 4-Azido-4-deoxy-neu5,7,8,9ac(4)2en1me. A Key Intermediate for the Synthesis of Gg167 from D-Glucono-Delta-Lactone

Synthesis of C-Galactosyl Monoacylglycerol Analogs

Enhancement of Bioconversion Gangliosides to Monosialotetrahexosylganglioside by in Situ Sialic Acid Removal and Recovery

A modular chemoenzymatic cascade strategy for the structure-customized assembly of ganglioside analogs